Apollo Hospitals Celebrates Its Leadership as the Largest Cardiac Center of Excellence

0
340
Apollo Hospitals Celebrates Its Leadership as the Largest Cardiac Center of Excellence

Chennai, 28 September 2023: Apollo, the world’s largest integrated healthcare provider today announced its position as the largest Cardiac care program in India and one of the leading cardiac programs in the world in terms of scale, outcomes, complexity, diversity and access. Apollo’s unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries and providing the full spectrum of cardiac care services.

With a steadfast commitment to pioneering healthcare, Apollo has not only transformed lives but also redefined excellence in cardiovascular care.

The Cardiac Center of Excellence at Apollo Hospitals stands as a testament to the institution’s leadership, state-of-the-art facilities, exceptional clinical team, and ground-breaking technologies.  Spanning across 38 hospitals with 375+ consultants, Apollo is the first corporate hospital group and largest private tertiary care institution for cardiovascular sciences in India. It attracts patients across the globe (from over 140 countries) for best-in-class outcomes compared to international benchmarks and seamless service delivery at affordable price points. 

The clinical offering at Apollo is one of the most comprehensive in the world, providing treatment for coronary artery disease, structural heart disease, congenital heart conditions and heart failure through advanced modalities ranging from minimally invasive and robot assisted surgery, to technology-intensive complex transcatheter therapies to transplant services, critical care, post-op rehab services as well as a significant footprint in preventive cardiac care through India’s first AI driven cardiac risk prediction and disease prevention program- AICVD.

Some of the key highlights of Apollo’s Cardiovascular Center of Excellence include:

  1. Unprecedented Number of Procedures: Since its first angioplasty as well as its first cardiac surgery performed in 1986, Apollo has consistently set records in terms of volume of procedures performed. Year after year, our dedicated team of medical professionals has been conducting tens of thousands of successful procedures offering a new lease of life to patients. Since its inception, Apollo has conducted more than 300,000 angioplasties and 200,000 cardiac surgeries, a clear leader in the space.
  2. World-class Infrastructure and Technology: Apollo is credited with bringing world class tertiary care of international standards to the country. A key ingredient of this is the investment in state-of-the-art medical facilities to accommodate the growing need for advanced cardiac care. Apollo currently has nearly 50 catheterisation labs across 38 centers in India with a capacity of 10,000 beds.  Apollo’s Centers of Excellence are equipped with the latest technology and medical infrastructure spanning robotic surgery and endovascular robotic suites, high-end coronary imaging and precision intervention modalities, 3D electrophysiology suite, high end critical care and life support, high-end diagnostics and screening services to ensure it serves patients at the cutting edge of science.
  3. Exceptional Clinical Team: The heart of Apollo’s success lies in its exceptional team of healthcare professionals, including world-renowned cardiologists, cardiac surgeons, anaesthetists, physicians, nurses, technicians and support staff that work together as a joint heart team. Their commitment to providing compassionate, patient-centered care is second to none. The team currently stands at 375+ specialist clinicians (cardiologists and cardiothoracic surgeons) across all sub-specialties of cardiac sciences spanning interventional cardiology, medical and preventive cardiology, cardiac surgery, minimally invasive and robotic surgery, electrophysiology, transplant and paediatric cardiology & CT surgery.
  4. High end and complex Procedures: Apollo Hospitals has shaped the growth of cardiac therapies in India by being innovators and early adopters of advanced and high-risk modalities. It has the largest Robotic Cardiac Surgery program in the country with more than 500 surgeries under its belt.  It has led the way in structural heart disease treatments with 500+ transcatheter aortic valve implantation (TAVI) procedures and nearly 70% of the Mitraclip implantations (to treat mitral valve regurgitation) in the country.  Apollo has pioneered the Emergency Medicine specialty by codifying ACS (Acute Coronary Syndrome) protocols to manage and treat cases of heart-attack.  It is also the first private hospital to perform a heart transplant.  It continues to perform a heavy mix of complex and high-risk procedures that many other hospitals are not equipped to do.                
  5. AICVD Tool: Apollo is proud to announce that 1 million patients have taken the AICVD test score.  AICVD predicts, with more than 90% accuracy, the risk of developing coronary artery disease in next 10 years.  A prospective study of these patients has reinforced the predictive power of this proprietary AI model.

Dr. Prathap C. Reddy, Chairman of Apollo said “Having been a practicing cardiologist, I have been particularly invested in the growth and development of Cardiac Sciences at Apollo. Our first angioplasty and bypass surgery in 1986 marked the beginning of an incredible journey.  Since then, our relentless commitment to healthcare involving adoption of the latest and safest methods with ethical execution and wide reach have helped us perform over 200,000 cardiac surgeries and over 300,000 angioplasties across Apollo Hospitals Group with millions of patients under a long-term cardiac care plan. ”  

Dr Sangita Reddy, Joint Managing Director, Apollo said ” Our next frontier is the battle against the NCD epidemic where we aim to stem the incidence of cardiovascular diseases and ensure early detection. . Apollo has launched a first-of-its kind artificial intelligence (AI) driven personalised preventive health program called ‘ProHealth’.  The need of the hour is true personalisation and prediction accompanied with ongoing health mentorship.  Our revolutionary cardiac risk prediction tool, AICVD, has shown that one can expect a 90% predictive success in detecting coronary artery disease 10 years in advance.  This information can be vital and life-changing in terms of preventing and managing heart disease proactively. We are happy to share this risk prediction model with everyone including the government since it would be a valuable tool in population health

As Apollo Hospitals celebrates this remarkable milestone, it reaffirms its commitment to delivering excellence in cardiovascular care and advancing the frontiers of medicine. The institution remains steadfast in its mission to heal and transform lives through innovative and compassionate healthcare.